An analysis of cytokines for venous thrombosis and pulmonary embolism risk associated with lung cancer

An analysis of cytokines for venous thrombosis and pulmonary embolism risk associated with lung cancer - An analysis of cytokines for venous thrombosis and pulmonary embolism risk associated with lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003924

Enrollment

Registered

2010-07-17

Start date

2010-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histologically or cytologically proven non-small cell lung cancer. 2) Adequate renal function to receive enhanced CT scans

Exclusion criteria

Exclusion criteria: Inappropriate patients for this study judged by the physicians Patients can not agree to participate in this trial.

Design outcomes

Primary

Measure	Time frame
1) Incidence of venous thrombosis and pulmonary embolism. 2) Impact of venous thrombosis and pulmonary embolism for survival and treatment. 3) To evaluate immunohistological and serum cytokines such as VEGF.	—

Countries

Japan

Contacts

Public ContactHironori Uruga

Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL Department of Respiratory Medicine

Outcome results